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Objectives: This study tested the hypothesis that silent embolic infarcts on computed tomography (CT) brain scans can
predict ipsilateral neurologic hemispheric events and stroke in patients with asymptomatic internal carotid artery stenosis.
Methods: In a prospective multicenter natural history study, 821 patients with asymptomatic carotid stenosis graded with
duplex scanning who had CT brain scans were monitored every 6 months for a maximum of 8 years. Duplex scans were
reported centrally, and stenosis was expressed as a percentage in relation to the normal distal internal carotid criteria used
by the North American Symptomatic Carotid Endarterectomy Trialists. CT brain scans were reported centrally by a
neuroradiologist. In 146 patients (17.8%), 8 large cortical, 15 small cortical, 72 discrete subcortical, and 51 basal ganglia
ipsilateral infarcts were present; these were considered likely to be embolic and were classified as such. Other infarct types,
lacunes (n  15), watershed (n  9), and the presence of diffuse white matter changes (n  95) were not considered to
be embolic.
Results: During a mean follow-up of 44.6 months (range, 6 months-8 years), 102 ipsilateral hemispheric neurologic
events (amaurosis fugax in 16, 38 transient ischemic attacks [TIAs], and 47 strokes) occurred, 138 patients died, and 24
were lost to follow-up. In 462 patients with 60% to 99% stenosis, the cumulative event-free rate at 8 years was 0.81 (2.4%
annual event rate) when embolic infarcts were absent and 0.63 (4.6% annual event rate) when present (log-rank P 
.032). In 359 patients with <60% stenosis, embolic infarcts were not associated with increased risk (log-rank P  .65).
In patients with 60% to 99% stenosis, the cumulative stroke-free rate was 0.92 (1.0% annual stroke rate) when embolic
infarcts were absent and 0.71 (3.6% annual stroke rate) when present (log-rank P  .002). In the subgroup of 216 with
moderate 60% to 79% stenosis, the cumulative TIA or stroke-free rate in the absence and presence of embolic infarcts was
0.90 (1.3% annual rate) and 0.65 (4.4% annual rate), respectively (log-rank P  .005).
Conclusion: The presence of silent embolic infarcts can identify a high-risk group for ipsilateral hemispheric neurologic
events and stroke and may prove useful in the management of patients with moderate asymptomatic carotid stenosis.
(J Vasc Surg 2009;49:902-9.)Currently, the decision to perform prophylactic carotid
endarterectomy (CEA) in asymptomatic patients is based
mainly on the presence of a hemodynamically significant
60% to 99% internal carotid artery stenosis in relation to the
normal lumen of the distal internal carotid artery. Com-
pared with best medical treatment alone, this strategy re-
duces the risk of ipsilateral stroke, as shown by the Veterans
Administration (VA) study, the Asymptomatic Carotid
Atherosclerosis Study (ACAS), and the Asymptomatic Ca-
rotid Surgery Trial (ACST).1-3 The midterm overall risk
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902reduction is minimal, however; the ACAS reported that in
patients with stenosis 60%, CEA reduced the annual risk
of stroke from 2% to 1%, which implies that approximately
20 procedures need to be performed to prevent one stroke
in 5 years.
For this reason, there is considerable debate on the
appropriateness of this procedure in all patients with
asymptomatic carotid stenosis,4-6 and restriction to pa-
tients who are at high risk of developing neurologic
events might be more cost-effective.1,7 Previous studies
in asymptomatic patients have associated severe carotid
stenosis,8-10 echolucent and heterogeneous carotid
plaques on ultrasound imaging,9 and carotid stenosis
with contralateral carotid artery occlusion3,11 with an
increased rate of ipsilateral neurologic events. In con-
trast, a more conservative approach would certainly be
desired in very elderly patients,12 in settings where the
operative stroke risk is high, or in patients with very low
stroke risk without surgery,13 because CEA is less cost-
effective in those circumstances.
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netic resonance imaging (MRI) or computed tomography
(CT) scanning has been associated with an increased risk of
stroke in the general population,14-16 in the perioperative
period in patients having CEA,17 and during long-term
follow-up after CEA.18 The aim of the present study was to
test the hypothesis that silent embolic infarcts on CT brain
scans can predict ipsilateral neurologic hemispheric events
and stroke in patients with asymptomatic internal carotid
artery stenosis.
METHODS
During a 5-year period, 1121 patients with asymptom-
atic carotid stenosis graded with duplex scanning were
enrolled in the Asymptomatic Carotid Stenosis and Risk of
Stroke (ACSRS) prospective natural history study. CT
brain scanning upon admission to the study was optional
and performed in 821 patients who are the subjects of this
report.
Aims of ACSRS study. ACSRS is an international
multicenter study under the auspices of the International
Union of Angiology aiming to study patients with asymp-
tomatic 50% to 99% stenosis in relation to the carotid bulb
diameter according to the European Carotid Stenosis Trial
(ECST) method and to monitor them for at least 5 years to
identify subgroups at high and low risk for future neuro-
logic events.
The study protocol was approved by the Multicenter
Research Ethics Committee (North Thames, London,
United Kingdom), and local ethics committees and pa-
tients were admitted to the study after informed consent.
The methodology used in the ACSRS study, eligibility of
participating centers, and quality control procedures have
been published in detail previously.19 A brief outline of the
methodology used in ACSRS is presented.
Admission to the study. Patients with internal ca-
rotid artery diameter stenosis 50% (ECST method) on
duplex scanning who had never had any ipsilateral hemi-
spheric or retinal symptoms and did not have any neuro-
logic abnormality on examination were eligible for ad-
mission to the study. Patients who had contralateral
hemispheric symptoms were also included provided they
had been asymptomatic for at least 6 months at the time
of recruitment. The side with the more severe stenosis
was considered to be the ipsilateral side for any patient
with bilateral stenosis.
Risk factors. The presence of conventional athero-
sclerotic risk factors, their duration, and severity, including
the presence of cardioembolic conditions (atrial fibrillation
and history of myocardial infarction), was recorded.
Grading of ICA stenosis. Duplex scanning was per-
formed on admission to the study and subsequently every 6
months to grade internal carotid artery stenosis. The team,
which included a neurologist, reviewed each patient at all
visits to provide clinical information. Doppler velocity re-
cordings in the common and internal carotid arteries were
obtained with the ultrasound beam as close as possible to an
angle of 60° to the axis of flow. Velocity criteria used forgrading the degree of stenosis in terms of the method used
in the ECST (stenosis in relation to the carotid bulb diam-
eter) and the North American Symptomatic Carotid End-
arterectomy Trial (NASCET)method (percentage of diam-
eter stenosis in relation to the normal distal internal
carotid) have been previously published.20
Because absolute velocity measurements could under-
estimate stenosis (eg, in the presence of cardiac arrhythmia)
or overestimate stenosis (eg, in the presence of severe
contralateral disease), the ultrasonographers at each center
were trained to use a combination of absolute intrastenotic
peak systolic and diastolic velocity measurements and ve-
locity ratios, using the prestenotic common carotid artery
as reference point. For the purpose of the current study, the
NASCET method was used to grade carotid artery stenosis
and is reported as such throughout the current report.
In plaques that were not calcified, anatomic criteria
(percentage diameter stenosis) using color flow or power
Doppler imaging of the artery in transverse section was
used to supplement velocity criteria. The entire duplex
examination was recorded on videotape and reported cen-
trally.
CT brain scanning. Noncontrast CT brain scan films
were reported centrally by an experienced neuroradiologist
(J. S.), and any ischemic damage was classified using the
Stevens classification:21
1. Discrete subcortical were small, well-circumscribed hy-
podense lesions, usually only a little greater than 1 cm in
size, adjacent to apparently noninvolved cerebral cortex
in the anterior and middle cerebral artery territory.
2. Large cortical infarcts had cortical distribution occupy-
ing usually 50% of the entire anterior and middle
cerebral artery territories.
3. Small cortical infarcts had cortical distribution occupy-
ing usually substantially50% of the entire anterior and
middle cerebral artery territories.
4. Basal ganglia infarcts were one or more circumscribed
lesions in the basal ganglia or thalami, usually about
1 cm.
5. Watershed infarction involved cortical and subcortical
regions at the periphery of the middle cerebral artery
supply territory.
6. Diffuse white matter low-density changes were areas of
poorly circumscribed low density in the cerebral white
matter, usually bilaterally.
7. Lacunar state was multiple hypodensities in the basal
ganglia and thalami, bilaterally.
Categories 1 through 4 were regarded as “embolic”
(Fig 1) and categories 5 through 7 were classified as “non-
embolic.” A normal CT brain scan or a scan showing
unrelated pathology was considered as normal.
End points. Primary end points were (1) ipsilateral
hemispheric ischemic stroke, including fatal stroke, defined
as a hemispheric neurologic deficit lasting 24 hours; (2)
any stroke; (3) ipsilateral hemispheric transient ischemic
attacks (TIAs); (4) amaurosis fugax; and (5) death from
cardiovascular causes other than stroke.19 A special form
show
JOURNAL OF VASCULAR SURGERY
April 2009904 Kakkos et alwas completed locally for reported strokes, and two
members of the coordinating team, which included a
neurologist, made the final classification. The local team
made the diagnosis of TIAs or amaurosis fugax. Patients
were followed up every 6 months for a maximum of 8
years.
Exit points. Exit points are any of the above end
points, death from any cause, ipsilateral CEA, stenting, or
loss to follow-up. Thus, patients who died, had an ipsilat-
eral CEA or stenting, or had an ipsilateral ischemic event
were followed up to the event only. Apart from the ipsilat-
eral fatal strokes, no overlap occurred between these events.
Quality control. Results of the quality control, al-
ready published,19 indicate that the goal of prospectively
controlling quality in the ACSRS study has been achieved.
Statistical analysis. Data were analyzed using SPSS
11 statistical software (SPSS Inc, Chicago, Ill). The 2 test
and relative risk was used to test the significance of the
incidence of neurologic event rates in relation to different
types of plaque. Kaplan-Meier curves were used for cumu-
lative stroke-free survival rates and the log-rank test for
significance of difference between curves. Cox regression
was used to calculate hazard ratios (HR) and 95% confi-
dence intervals (CI). Logistic regression was used to iden-
tify independent predictors of neurologic events. The level
Fig 1. Typical examples of embolic infarction are
(C) subcortical, and (D) basal ganglia infarct. Arrowsof significance was considered as P  .05.RESULTS
The study enrolled 328 women and 493 men with a
median age of 71 years (interquartile range [IQR], 65-75
years). Stenosis severity distribution in relation to gender is
summarized in Table I. On admission to the study, 8 large
cortical, 15 small cortical, 72 discrete subcortical, and 51
basal ganglia ipsilateral infarcts were present in 146 pa-
tients. Other ipsilateral infarct types included 15 lacunes
and 9 watershed infarcts, and diffuse white matter changes
were also diagnosed in 95 patients. The distribution of
embolic and nonembolic infarction in the ipsilateral and
n, including (A) large cortical, (B) small cortical,
the corresponding brain infarct.
Table I. Stenosis severity distribution in relation to
gendera
Stenosis severity
Gender, No. (%)
All patients
(n  821),
No. (%)
Female
(n  328)
Male
(n  493)
60% 137 (39.1) 213 (60.9) 350 (100)
60% to 79% 94 (41.4) 133 (58.6) 227 (100)
80% to 99% 97 (39.8) 147 (60.2) 244 (100)
aA uniform distribution was noted (P  .86).showcontralateral hemisphere is compiled in Table II. A signifi-
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eral embolic infarction and other infarct types (watershed
and basal ganglia lacunes, in both the ipsilateral and con-
tralateral brain hemispheres) was found; results are summa-
rized in Table III.
Patients were monitored for a mean of 44.6 months
(range, 6 months-8 years). During that time, 102 ipsilateral
hemispheric neurologic events (amaurosis fugax in 16, TIA
in 39, and stroke in 47) were observed, 138 patients died,
and 24 were lost to follow-up. The ipsilateral hemispheric
event rate in relation to the presence of embolic brain
infarction was stratified by stenosis severity.
In 359 patients with 60% stenosis, the presence of
embolic infarcts in 60 patients was not associated with
increased risk (1.66% annual event rate) compared with
patients where these were absent (2.38% annual event rate,
log-rank P  .65; Cox regression HR, 1.14; 95% CI,
0.50-2.58). However, in 462 patients with 60% to 99%
stenosis, the cumulative event-free rate at 8 years was 0.81
(2.4% annual event rate) in the absence of embolic infarcts
and 0.63 (4.6% annual event rate) in the 86 patients where
they were present (log-rank P .032, Fig 2; Cox regression
HR, 1.82; 95% CI, 1.05-3.14).
Subgroup analysis for stroke revealed similar findings.
In patients with 60% to 99% stenosis, the cumulative
stroke-free rate was 0.92 (1.0% annual stroke rate) in the
absence of embolic infarcts and 0.71 (3.6% annual stroke
rate) in their presence (log-rank P  .002, Fig 3; Cox
regression HR, 3.0; 95% CI, 1.46-6.29). A similar associa-
tion in 60% stenoses was not observed, where the pres-
ence of embolic infarcts was not associated with increased
stroke risk (0.48% annual stroke rate) compared with pa-
tients in whom these were absent (1.1% annual stroke rate,
log-rank P  .76; Cox regression HR, 0.72; 95% CI,
0.16-3.20).
Finally, in the subgroup of 216 patients with moderate,
Table II. Distribution of embolic and nonembolic
infarcts in the ipsilateral and contralateral brain
hemispheresa
Infarct type
Brain hemisphere, No.
Ipsilateral Contralateral
Embolic
Discrete subcortical 72 75
Large cortical 8 11
Small cortical 15 36
Basal ganglia 51 64
Nonembolic
Watershed 9 12
Diffuse white matter changes
Mild 59 57
Moderate 31 34
Severe 5 5
Basal ganglia lacunar 15 14
aMore infarcts were seen in the contralateral hemisphere. Note that some
subjects had had symptoms in the contralateral hemisphere 6 months
before entering the study.60% to 79% stenosis, the cumulative TIA or stroke-free ratein the absence and presence of embolic infarcts was 0.90
(1.3% annual rate) and 0.65 (4.4% annual rate), respectively
(log-rank P  .005; Fig 4). Compared with normal CT
brain scans, the presence of nonembolic brain infarction
(watershed, lacunes) or diffuse white matter changes had
no effect on rates of ipsilateral neurologic events (P 
.63) or stroke (P  .67); similar nonsignificant results
were obtained from subgroup analysis by stenosis sever-
ity (Fig 5).
Multivariate logistic regression with ipsilateral embolic
infarcts, degree of stenosis (60%, 60% to 79%, 80% to
99%), age, gender, history of myocardial infarction, ar-
rhythmia, and use of antiarrhythmic medications, antiplate-
let use, and anticoagulant therapy as independent variables,
identified embolic infarcts (relative risk, 2.0; 95% CI, 1.1-
3.8; P .033) and degree of stenosis (relative risk, 1.6; 95%
CI, 1.1-2.5; P  .019) as independent predictors of ipsi-
lateral neurologic events.
DISCUSSION
In ACSRS we demonstrated that the presence of silent
embolic infarcts in the ipsilateral brain hemisphere in pa-
tients with moderate and severe asymptomatic carotid ar-
tery stenosis was associated with an increased risk of ipsilat-
eral hemispheric neurologic events and stroke compared
with patients without such infarcts. This difference may
prove useful in the management of patients with asymp-
tomatic carotid disease by identifying a high-risk group for
neurologic events, including those with moderate carotid
stenosis (60% to 79% range) who are poor surgical candi-
dates (eg, positive stress echo) and in whommany surgeons
are more conservative in treating with CEA or angioplasty
and stenting.
The prevalence of SBIs on CT brain scanning in pa-
tients with asymptomatic carotid stenosis was 18% in our
study; similar rates varying between 10% and 24% have been
reported.18,22-24 Baseline SBIs in the ACAS was 15%,22
and 72% were described as being small and deep. This is
consistent with our study, where most patients had subcor-
tical and basal ganglia infarcts.
The SBIs in ACAS were evenly distributed ipsilaterally
and contralaterally to the study carotid artery. Neurologic
examination factors such as abnormal gait and abnormal
deep tendon reflexes or plantar responses were associated
with SBI, but not the degree of carotid stenosis.22 In ACST
the incidence of SBI on CT or MRI brain scanning in
contralateral hemispheres that never had neurologic symp-
toms was 10% and 14%, respectively.23 Norris and Zhu
reported a 19% incidence of SBI in asymptomatic carotid
stenosis,24 whereas Cao18 reported a 24% incidence of SBI
(15% lacunes, 9% nonlacunes) in patients with 60%
asymptomatic carotid artery stenosis undergoing CEA.
Direct comparison of these studies is difficult because
of different SBI classification schemes. To overcome this
potential problem, central reporting was performed in
ACSRS.
The mechanism of SBI has been the subject of several
studies. Most SBIs are embolic in nature (as defined in
tralat
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embolism. Reports indicate the severity of asymptomatic
carotid stenosis is associated with the appearance of
SBIs.24,25 Like other studies,26 such an association was not
found in our study, however, when stenoses were stratified
Table III. Distribution of contralateral embolic infarction
infarction on computed tomography scanning
Type
Ipsilateral emboli
Present (n  146)
Other infarct types, ipsilaterally 21 (14.4)
Contralateral embolic infarction 81 (55.5)
Other infarct types, contralaterally 17 (11.6)
CI, Confidence interval; OR, odds ratio.
aThese included watershed and basal ganglia lacunes in the ipsilateral or con
Fig 2. Ipsilateral hemispheric neurologic event-free rate is shown
in 462 patients with 60% to 99% carotid artery stenosis in relation
to“embolic” infarction on computed tomography (CT) brain
scanning. The number of patients at risk at each interval is shown at
the bottom of the figure.
Fig 3. Stroke-free rate is shown in 462 patients with 60% to 99%
carotid artery stenosis in relation to “embolic” infarction on com-
puted tomography (CT) brain scanning. The number of patients at
risk at each interval is shown at the bottom of the figure.using a 60% NASCET cutoff.Plaques that appear ulcerated on B-mode ultrasound
imaging in asymptomatic patients were also closely related
to the appearance of silent infarcts on MRI.25 Similarly,
other infarct typesa in relation to “embolic” brain
rction, No. (%)
P OR (95% CI)Absent (n  675)
3 (0.4) .001 37.6 (11.1-128.1)
91 (13.5) .001 8.0 (5.4-11.9)
8 (1.2) .001 11.0 (4.6-26.0)
eral hemisphere.
Fig 4. Ipsilateral hemispheric transient ischemic attack (TIA) and
stroke-free rate are shown in 216 patients with moderate (60% to
79%) carotid artery stenosis in relation to “embolic” infarction on
computed tomography (CT) brain scanning. The number of pa-
tients at risk at each interval is shown at the bottom of the figure.
Fig 5. Ipsilateral hemispheric event-free rate is shown in 462
patients with 60% to 99% carotid artery stenosis in relation to
“embolic” infarction, “non-embolic” infarction, and normal find-
ings on computed tomography (CT) brain scanning. No differ-
ence between the last two groups was found. The number of
patients at risk at each interval is shown at the bottom of the figure.and
c infacarotid plaques that are associated with nonlacunar SBIs on
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or no infarcts.27 These indicators of plaque instability,
known to be associated with brain infarction in symptom-
atic patients,28,29 might be also responsible for embolic
SBIs in asymptomatic carotid artery stenosis; obviously,
some of the embolic SBIs in this patient population are of
cardiac origin. This is supported by the associations be-
tween “embolic” and “nonembolic” SBIs that is summa-
rized in Table III.
Several natural history studies have investigated the role
of SBIs on predicting future stroke. Three reported on the
prognostic role of MRI-detected SBIs,14-16 but unfortu-
nately, the status of the carotid arteries was not investi-
gated. In a study conducted in Japan, subcortical SBI on
MRIwas an independent risk factor for clinical stroke14 and
associated with a 3.6% annual stroke risk. A similar associ-
ation between silent MRI infarcts and the risk of future
stroke were found in the cardiovascular health study.15 The
incidence of stroke was much higher in participants with
SBIs than without such a finding, at 18.7 vs 9.5/1000
person-years (HR, 1.5; 95% CI, 1.1-2.1), but again, the
status of the carotid arteries was not reported.
SBIs found on MRI also increased stroke risk in the
general population as shown by the Rotterdam Scan
Study.16 The absolute stroke risk at 4 years in the presence
and absence of SBI was 11.7% and 2.3%, respectively, and
this absolute risk was five times higher for participants with
one or more SBIs on MRI compared with those without.
Regarding the significance of SBI detected on CT scan-
ning, Cao reported a10-year stroke risk of 18% in patients
with SBI compared with 5% for absent SBI.18 Unlike the
MRI studies, patients in this study had CEA previously and
therefore the differential effect of carotid stenosis cannot be
tested.
Our group has previously reported that the presence of
embolic SBI on CT brain scanning was associated with an
increased stroke risk,27 but because this was a mixed group
of symptomatic and asymptomatic patients, the results can-
not be extrapolated to the latter group of patients. The
present study is therefore the first to report, to our knowl-
edge, the prognostic role of embolic SBIs in patients with
asymptomatic carotid stenosis. SBIs imply that the ICA
stenosis may have caused emboli, without symptoms be-
cause they occurred in silent areas. Alternatively, they may
have occurred during sleep or were misinterpreted.
The present study is also unique in the sense that we
included patients across a wide spectrum of carotid disease
severity; in patients with stenosis 60%, the presence of
embolic infarcts was not associated with increased risk,
probably because this subgroup was underpowered (both
small sample size and event rate). However, in patients with
coexisting hemodynamically significant stenosis, the annual
ipsilateral event rate was nearly doubled in patients who had
embolic infarcts (4.6%) compared with those that did not
(2.4%). Results on this subject from the randomized ACST
are awaited.23,30
It is possible that SBIs render the brain susceptible to
cumulative damage. This would be the reason SBI was a riskfactor for stroke complicating CEA in a previous study,17
possibly in association with carotid artery clamping–related
hypoperfusion. However, this association was not evident in
an earlier study18 in which SBI in patients undergoing CEA
for asymptomatic carotid stenosis was associated with a 1.8%
annual stroke risk during long-term follow-up compared with
0.5% for those without SBI.
Diminished collateral reserve capacity on cerebral an-
giography in association with SBIs on CT brain scanning in
patients with TIAs has also been demonstrated.31 Cerebral
hypoperfusion in half of the patients with asymptomatic
carotid stenosis, predominantly in patients with a hypoplas-
tic ipsilateral A1 segment, has been described.32 Another
study showed impaired cerebrovascular reserve capacity on
xenon-CT imaging with acetazolamide in patients in whom
new lesions developed on MRI during follow-up.33
The Rotterdam Scan Study showed that cardiovascular
risk factors for SBIs, which included age, blood pressure,
diabetes mellitus, cholesterol and homocysteine levels,
intima-media thickness, carotid plaques, and smoking were
associated with new SBIs in participants without prevalent
infarcts,34 whereas a prevalent SBI strongly predicted a new
SBI on the second MRI.
Another study highlighted that multiple mechanisms
might be involved with SBI when it showed that coronary
artery disease-atherosclerosis and hypertension were inde-
pendently involved.35 In addition, SBI in patients with a
first-ever stroke has been thought to be a marker of wide-
spread vascular disease.36 The results of our study, which
demonstrated that the risk for an event was largely in-
creased only in patients with a hemodynamically significant
stenosis, indicate a synergistic mechanism that involves an
endogenously and exogenously susceptible brain due to the
presence of infarction and significant carotid stenosis, re-
spectively.
Among the study limitations are that CT scanning
does not detect all SBIs. MRI detects a higher number of
brain infarcts in patients with asymptomatic carotid ar-
tery stenosis—42% in one study.25 At the time the study
was designed, most centers did not have MRI equip-
ment, and therefore CT scanning was the method of
choice. The role of brain MRI in stratifying patients with
carotid stenosis is warranted.
In conclusion, our study indicates that the presence of
silent “embolic” infarcts can identify a high-risk group for
ipsilateral hemispheric neurologic events and stroke and
may prove useful in the management of patients with
moderate asymptomatic carotid stenosis.
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